As the global leader in safeguarding high-value sample assets, Astoriom will be exhibiting at BioProcess International US West 2026 to connect with biopharma scientists, process development teams, CDMOs, and manufacturing leaders advancing biologics and advanced therapies. BPI West is a premier bioprocessing event bringing together hundreds of industry professionals to explore innovations across cell line development, manufacturing strategy, and next-generation biologics.
Meet us at Booth 907, where we will showcase how our multi-temperature biorepository, stability storage, and disaster recovery solutions support complex biologics pipelines from discovery through commercial manufacturing. With increasing pressure to accelerate timelines while maintaining quality and compliance, Astoriom provides purpose-built, validated infrastructure that protects critical materials, ensures regulatory readiness, and strengthens business continuity across the full product lifecycle.
Astoriom will also contribute to the panel discussion “Future Directions – Making Cell & Gene Therapies More Accessible and Attractive” (10 March, 11:45 AM). This session will explore how manufacturing innovation, digitalisation, and improved supply chains can expand patient access and support viable commercial pathways for advanced therapies. Our participation reflects Astoriom’s commitment to addressing one of the sector’s most pressing challenges: ensuring that breakthrough therapies can scale safely, reliably, and sustainably while protecting the integrity of the materials that underpin them.
